YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?
about
Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.Evaluating biomarkers in melanoma.YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional studyYKL-40 and genetic status of CHI3L1 in a large group of asthmaticsPlasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII StudyThe inflammatory biomarker YKL-40 decreases stepwise after exercise stress test.hYKL-40 cancer biomarker electroanalysis in serum samples and model cell lysates: capacitive immunosensing compared with enzyme label immunosorbent assays (ELISA).Chitosan leads to downregulation of YKL-40 and inflammasome activation in human macrophages.YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layersThe inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality.YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.A novel biomarker-based analysis reliably predicts nodal metastases in anal carcinoma: preliminary evidence of therapeutic impact.Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trial.The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis.YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
P2860
Q34806348-63066716-5980-4544-9DCA-46AED80A4C67Q35005677-4D47CD64-69C6-418F-8D7D-6EB31C47DD31Q35433475-DDFD6F53-A448-49CE-9D49-ABFA8543F01DQ36300687-F11FE9DC-70F4-402C-AC8B-2289508FAB1BQ37548804-76CAC9A4-43ED-4104-AFC1-D0D89A024FC4Q37722600-9F4BDF2F-D8ED-4EFB-8D21-9A22A42917EEQ38720400-A653D6CA-BC10-4679-BBA3-95E96E337AC5Q38909229-B826FC2E-1C6E-4567-852E-F278559DD7AAQ39433175-6C9B7472-36B9-4780-86A8-FC7946568692Q43834139-CEEB3DBB-07DA-4716-8C3A-50AF53156F4AQ45811351-1F2F8B25-A43D-4C00-8580-4DAAF33EC96FQ46109058-5EDEC5D6-8526-4F9A-8852-553A39B2631FQ48049656-056154BE-502B-437D-92CC-94772955C753Q50293199-29924A68-E643-4A29-BD0A-D3716D8AE3B3Q52593486-800758AB-46A0-4B96-A42E-5EF08128B8B0Q53204820-D9770580-AC23-400C-B6EB-70244C544A1A
P2860
YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
YKL-40-A Protein in the Field ...... Biomarker in Cancer Patients?
@en
YKL-40-A Protein in the Field ...... Biomarker in Cancer Patients?
@nl
type
label
YKL-40-A Protein in the Field ...... Biomarker in Cancer Patients?
@en
YKL-40-A Protein in the Field ...... Biomarker in Cancer Patients?
@nl
prefLabel
YKL-40-A Protein in the Field ...... Biomarker in Cancer Patients?
@en
YKL-40-A Protein in the Field ...... Biomarker in Cancer Patients?
@nl
P2860
P356
P1433
P1476
YKL-40-A Protein in the Field ...... Biomarker in Cancer Patients?
@en
P2093
Julia S Johansen
Nicolai A Schultz
P2860
P304
P356
10.3390/CANCERS2031453
P577
2010-07-12T00:00:00Z